Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $1.7
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald has maintained a 'Hold' rating on Aveanna Healthcare Hldgs (NASDAQ:AVAH) and raised the price target from $1.4 to $1.7.
July 13, 2023 | 4:41 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aveanna Healthcare Hldgs' price target has been raised from $1.4 to $1.7 by Truist Securities, while maintaining a 'Hold' rating.
The news directly pertains to Aveanna Healthcare Hldgs (AVAH). The 'Hold' rating suggests that the analyst does not see significant upside or downside in the short term. However, the increase in price target could be seen as a positive signal, potentially leading to a neutral to slightly positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100